The FDA granted orphan designation to Sanofi (SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on ...
Der französische Pharmagigant Sanofi will das Geschäft mit rezeptfreien Medikamenten an einen amerikanischen Finanzinvestor verkaufen. Zu dem Paket gehört auch das beliebteste Schmerzmittel des ...
Die Sanofi Dividende wird für das vergangene Geschäftsjahr auf der aktuellen Hauptversammlung von Sanofi festgelegt. Der Vorstand von Sanofi macht dabei zunächst einen Vorschlag für die Sanofi ...
Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products and could be used to respond to an emerging pandemic ...
Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 11,687.23 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...
While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that having MNC stocks in your portfolio is an assurance of growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback